Novanta Inc. $NOVT Stock Holdings Lifted by Krane Funds Advisors LLC

Krane Funds Advisors LLC raised its position in shares of Novanta Inc. (NASDAQ:NOVT) by 903.3% in the third quarter, Holdings Channel reports. The firm owned 15,782 shares of the technology company’s stock after buying an additional 14,209 shares during the period. Krane Funds Advisors LLC’s holdings in Novanta were worth $1,676,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Novanta by 4.6% in the 3rd quarter. Vanguard Group Inc. now owns 4,378,888 shares of the technology company’s stock valued at $438,546,000 after buying an additional 193,366 shares in the last quarter. Wasatch Advisors LP lifted its stake in Novanta by 10.6% in the second quarter. Wasatch Advisors LP now owns 1,100,029 shares of the technology company’s stock valued at $141,827,000 after acquiring an additional 104,985 shares during the last quarter. Geneva Capital Management LLC grew its position in Novanta by 5.9% in the second quarter. Geneva Capital Management LLC now owns 988,969 shares of the technology company’s stock worth $127,508,000 after acquiring an additional 54,934 shares in the last quarter. Geode Capital Management LLC grew its position in Novanta by 1.4% in the second quarter. Geode Capital Management LLC now owns 919,666 shares of the technology company’s stock worth $118,585,000 after acquiring an additional 12,789 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Novanta by 4.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 753,111 shares of the technology company’s stock worth $75,424,000 after purchasing an additional 30,674 shares during the last quarter. 98.35% of the stock is currently owned by institutional investors and hedge funds.

Novanta News Summary

Here are the key news stories impacting Novanta this week:

• Positive Sentiment: Headline Q4 results showed growth and an EPS beat: revenue was ~$258.3M (up ~8.5% YoY) and the company reported $0.91 EPS versus a ~ $0.88 consensus, supporting the view of sustained top‑line momentum. Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
• Positive Sentiment: Balance sheet strength: third‑party data flagged a large increase in cash and cash equivalents (~$381M, +234% YoY), which supports liquidity and buyback/dividend flexibility. Novanta Inc. (NOVT) Stock Falls on Q4 2025 Earnings
• Neutral Sentiment: FY 2026 guidance roughly in line with consensus: Novanta set FY EPS at $3.50–3.65 (consensus ~3.61) and revenue $1.0B–$1.1B — provides a roadmap but leaves upside dependent on execution. Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
• Neutral Sentiment: Market/valuation discussion and analyst prep pieces are assessing whether recent share momentum is justified given mixed signals from results and guidance. These pieces frame investor debate but don’t introduce new fundamentals. Assessing Novanta (NOVT) Valuation After Recent Share Price Momentum
• Negative Sentiment: Q1 2026 guidance disappointed: Novanta gave Q1 EPS of $0.75–0.80 vs. a ~$0.85 consensus and revenue guidance of $250–255M (vs. $253.3M consensus), prompting near‑term earnings growth concerns. Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
• Negative Sentiment: Operational/cash concerns flagged by third‑party reporting: operating profit and cash from operations showed strain (reports cite an ~85% drop in cash from ops YoY), and cost of sales rose — potential margin pressure to monitor. Novanta Inc. (NOVT) Stock Falls on Q4 2025 Earnings
• Negative Sentiment: Recent insider selling: the CEO sold shares earlier in Feb., which some investors view as a negative signal about near‑term insider conviction. Is Novanta Stock a Buy or Sell After Its CEO Dumped 6,500 Shares?

Insider Buying and Selling

In other news, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total value of $1,087,800.00. Following the sale, the chief executive officer owned 57,367 shares in the company, valued at approximately $8,320,509.68. This trade represents a 11.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Robert Buckley sold 1,423 shares of the business’s stock in a transaction on Wednesday, January 21st. The stock was sold at an average price of $140.14, for a total transaction of $199,419.22. Following the transaction, the chief financial officer directly owned 91,034 shares in the company, valued at $12,757,504.76. This trade represents a 1.54% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 22,923 shares of company stock worth $3,182,264 in the last ninety days. Insiders own 1.20% of the company’s stock.

Novanta Stock Performance

Shares of NOVT opened at $142.38 on Tuesday. The company has a market capitalization of $5.09 billion, a PE ratio of 96.86 and a beta of 1.62. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.51 and a quick ratio of 1.54. Novanta Inc. has a one year low of $98.27 and a one year high of $153.20. The company’s fifty day moving average price is $132.15 and its 200 day moving average price is $119.89.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.88 by $0.03. The company had revenue of $258.35 million for the quarter, compared to the consensus estimate of $260.72 million. Novanta had a return on equity of 14.53% and a net margin of 5.50%.Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. As a group, analysts expect that Novanta Inc. will post 3.03 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a research note on Friday, January 16th. Weiss Ratings upgraded Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, January 20th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $133.00.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.